LIQUIDITY AND OTHER UNCERTAINTIES (Details Narrative) - USD ($)		3 Months Ended						9 Months Ended
	Aug. 10, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022	Aug. 07, 2023	Dec. 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Net losses		$ 12,589,572	$ 6,003,233	$ 5,475,769	$ 5,681,574	$ 5,974,448	$ 4,578,660	$ 24,068,576	$ 16,234,682
Cash flows from operations								21,302,119	12,959,204
Cash and cash equivalents, at carrying value		3,287,902			39,428,850			3,287,902	39,428,850		$ 39,096,562
Marketable securities, current		34,627,782						34,627,782			9,848,804
Restricted cash		10,000,000						10,000,000
Working capital		$ 3,812,783						3,812,783
Proceeds from sale of convertible preferred stock								$ 21,632,156
Purchase agreement description								The certificate of designations for the Series H-7 Preferred Shares (the “Certificate of Designations”) contains certain restrictive provisions, including (i) a requirement to maintain unencumbered, unrestricted cash and cash equivalents on hand in an amount equal to (a) until December 31, 2023, at least $20,000,000 plus the net proceeds from the sale of the Series H-7 Preferred Shares pursuant to the Purchase Agreement, and (b) from January 1, 2024 and until an aggregate of eighty percent (80%) of the Series H-7 Preferred Shares have been converted into shares of common stock, at least $21,000,000, and (ii) a requirement to deposit an amount equal to $10,000,000 from the Private Placement proceeds into a newly established segregated deposit account of the Company (“Segregated Cash”), and to use such Segregated Cash solely for the purpose of performing the Company’s monetary obligations to the holders of the Series H-7 Preferred Shares, provided, however, that the Company may use the Segregated Cash for any purpose, including general corporate purposes, with the prior written consent of holders of at least 75% of the outstanding Series H-7 Preferred Shares. As of September 30, 2023, the Company was not in compliance with the restrictive provisions discussed above. The Company has regained compliance subsequent to September 30, 2023.
Series H-7 Convertible Preferred Stock [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Temporary equity shares issued		22,000						22,000			0
Temporary equity stated value		$ 1,000						$ 1,000
Securities Purchase Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Deposit amount	$ 10,000,000
Securities Purchase Agreement [Member] | Series H-7 Convertible Preferred Stock [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Temporary equity shares issued										22,000
Preferred stock, shares par value										$ 0.0001
Temporary equity stated value										$ 1,000
Aggregate exercisable shares of coomon stock										2,750,000
Proceeds from sale of convertible preferred stock	$ 22,000,000